Golden Ten data, January 16 news, on January 15, Jiudian Pharmaceutical big dump 9.86%. As of the midday closing today, the stock fell 1.34%, with a total Market Cap of about 7.7 billion yuan. On the news front, on January 15, a screenshot of a suspected Luoxuofen Sodium Gel Patch from Le Ming Pharmaceutical circulated in the market. In response, a person related to the company as an investor called Jiudian Pharmaceutical, and responded that the company learned of the relevant market rumors yesterday, immediately verified through official channels and third-party professional data platforms, did not obtain relevant information, and could not confirm the authenticity of the rumors. Regarding whether the approval of competing products will affect the company, the person said that if new competitors enter, it will definitely have a certain impact on the company. However, as Luoxuofen Sodium Gel Patch is a generic drug, it has attracted dozens of companies to apply for approval in the past two years, so it is normal for products to be approved.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
